Evidence map›Paper›PMID 31110045›Full record

ArticleThe Journal of biological chemistry2019

Disruption of the SucT acyltransferase in

Zuzana Palčeková, Shiva K Angala, Juan Manuel Belardinelli, Haig A Eskandarian, Maju Joe, Richard Brunton, Christopher Rithner, Victoria Jones, Jérôme Nigou, Todd L Lowary and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Lipoarabinomannan modification as a source of phenotypic heterogeneity in host-adaptedProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Editorial: Host immune evasion byFrontiers in immunology · 2022
    Article
  19. Arabinogalactan enhancesFrontiers in immunology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 4 countries.

Zuzana PalčekováFrom the Mycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado 80523-1682.
Shiva K AngalaFrom the Mycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado 80523-1682.
Juan Manuel BelardinelliFrom the Mycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado 80523-1682.ORCID 0000-0003-1336-9141
Haig A Eskandarianthe Global Health Institute, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne VD, Switzerland.ORCID 0000-0002-0610-0550
Maju Joethe Alberta Glycomics Centre and Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada.
Richard Bruntonthe Alberta Glycomics Centre and Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada.
Christopher Rithnerthe Central Instrumentation Facility, Department of Chemistry, Colorado State University, Fort Collins, Colorado 80523-1872, and.
Victoria JonesFrom the Mycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado 80523-1682.
Jérôme Nigouthe Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, 205 Route de Narbonne, 31077 Toulouse, France.
Todd L Lowarythe Alberta Glycomics Centre and Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada.ORCID 0000-0002-8331-8211
Martine Gilleronthe Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, 205 Route de Narbonne, 31077 Toulouse, France.
Michael McNeilFrom the Mycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado 80523-1682.
Mary JacksonFrom the Mycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado 80523-1682, Mary.Jackson@colostate.edu.ORCID 0000-0002-9212-0258
Colorado State University · USUniversity of Alberta · CACentre National de la Recherche Scientifique · FRÉcole Polytechnique Fédérale de Lausanne · CH

Funding

Biogenesis of Lipoarabinomannan in MycobacteriaR01AI064798 · NIAID · COLORADO STATE UNIVERSITY-FORT COLLINS · PI JACKSON, MARY · 2005 to 2019
$5.4M
Mycobacterium tuberculosis methylglucose lipopolysaccharidesR21AI144344 · NIAID · COLORADO STATE UNIVERSITY · PI JACKSON, MARY · 2019 to 2020
$418k
NIAID NIH HHS R01 AI064798NIAID NIH HHS R21 AI144344
6 · The paper itself

Abstract

Similar to other prokaryotes, mycobacteria decorate their major cell envelope glycans with minor covalent substituents whose biological significance remains largely unknown. We report on the discovery of a mycobacterial enzyme, named here SucT, that adds succinyl groups to the arabinan domains of both arabinogalactan (AG) and lipoarabinomannan (LAM). Disruption of the SucT-encoding gene in

Indexed as

AcyltransferasesBacterial ProteinsCell WallGalactansLipopolysaccharidesMutationMycobacterium smegmatisSuccinatesAcyltransferasesarabinogalactanBacterial ProteinsGalactanslipoarabinomannanLipopolysaccharidesSuccinatesarabinogalactancell surfacelipoarabinomannanmycobacteriaMycobacterium smegmatispolysaccharidesuccinylationtuberculosis

Identifiers

PMID31110045
PMCPMC6664188
OpenAlexW2946530668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.